Cardiac biomarkers, including high-sensitivity cardiac troponin T (hs-cTnT) and amino-terminal pro-B-type natriuretic peptide (NT-proBNP), can enhance the recognition of HF among at-risk individuals, including T2DM, when combined with traditional risk scores [12]. Here, NPPB is linked to hydrops fetalis.